DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,630,620 | -46.7% | 91,216 | -48.4% | 0.09% | +64.2% |
Q2 2023 | $42,431,083 | +721.5% | 176,706 | +762.9% | 0.05% | -48.5% |
Q1 2023 | $5,165,346 | +15.4% | 20,478 | -3.6% | 0.10% | +80.7% |
Q4 2022 | $4,475,771 | -27.8% | 21,247 | -11.4% | 0.06% | -26.9% |
Q3 2022 | $6,197,000 | +20.1% | 23,970 | +17.7% | 0.08% | +23.8% |
Q2 2022 | $5,160,000 | -9.1% | 20,373 | +5.4% | 0.06% | +6.8% |
Q1 2022 | $5,677,000 | -26.1% | 19,334 | -17.1% | 0.06% | -20.3% |
Q4 2021 | $7,680,000 | -16.0% | 23,333 | -22.2% | 0.07% | -39.8% |
Q3 2021 | $9,141,000 | +22.9% | 30,005 | +8.3% | 0.12% | +17.1% |
Q2 2021 | $7,437,000 | +41.5% | 27,693 | +18.7% | 0.10% | +26.5% |
Q1 2021 | $5,257,000 | +16.4% | 23,336 | +14.8% | 0.08% | +13.7% |
Q4 2020 | $4,517,000 | +4.5% | 20,319 | +1.3% | 0.07% | -9.9% |
Q3 2020 | $4,324,000 | +19.7% | 20,063 | -1.7% | 0.08% | +2.5% |
Q2 2020 | $3,611,000 | +116.1% | 20,403 | +69.2% | 0.08% | +54.9% |
Q1 2020 | $1,671,000 | +17.8% | 12,056 | +30.6% | 0.05% | +34.2% |
Q4 2019 | $1,418,000 | +23.4% | 9,228 | +16.1% | 0.04% | +8.6% |
Q3 2019 | $1,149,000 | -11.4% | 7,947 | -12.3% | 0.04% | -12.5% |
Q2 2019 | $1,297,000 | +7.6% | 9,061 | -0.6% | 0.04% | -14.9% |
Q1 2019 | $1,205,000 | +51.2% | 9,115 | +18.1% | 0.05% | 0.0% |
Q4 2018 | $797,000 | – | 7,718 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |